83 related articles for article (PubMed ID: 35696735)
1. Profiling hepatocellular carcinoma aggressiveness with contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI: An intra-individual comparative study based on the Liver Imaging Reporting and Data System.
Yang J; Jiang H; Xie K; Bashir MR; Wan H; Huang J; Qin Y; Chen J; Lu Q; Song B
Eur J Radiol; 2022 Sep; 154():110397. PubMed ID: 35696735
[TBL] [Abstract][Full Text] [Related]
2. The comparison of contrast-enhanced ultrasound and gadoxetate disodium-enhanced MRI LI-RADS for nodules ≤2 cm in patients at high risk for HCC: a prospective study.
Qin Z; Zhou Y; Zhang X; Ding J; Zhou H; Wang Y; Zhao L; Chen C; Jing X
Front Oncol; 2024; 14():1345981. PubMed ID: 38774417
[TBL] [Abstract][Full Text] [Related]
3. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
[TBL] [Abstract][Full Text] [Related]
4. The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
Pan J; Song M; Yang L; Zhao Y; Zhu Y; Wang M; Chen F
Eur Radiol; 2023 Aug; 33(8):5801-5811. PubMed ID: 36894754
[TBL] [Abstract][Full Text] [Related]
5. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
Li L; Zheng W; Wang J; Han J; Guo Z; Hu Y; Li X; Zhou J
AJR Am J Roentgenol; 2022 Sep; 219(3):434-443. PubMed ID: 35441534
[No Abstract] [Full Text] [Related]
6. LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging.
Jang HJ; Choi SH; Choi SJ; Choi WM; Byun JH; Won HJ; Shin YM
Eur Radiol; 2023 Aug; 33(8):5792-5800. PubMed ID: 37017700
[TBL] [Abstract][Full Text] [Related]
7. Performance of current versus modified CEUS LI-RADS in the diagnosis of non-hepatocellular carcinoma malignancies.
Wen R; Huang F; Lin P; Gao R; Pang J; Wu Y; Yin H; Tang Z; Ma Z; He Y; Yang H
Abdom Radiol (NY); 2023 Dec; 48(12):3688-3695. PubMed ID: 37726380
[TBL] [Abstract][Full Text] [Related]
8. Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.
Wen R; Huang W; Song R; Qin L; Wu Y; Peng Y; Huang X; He Y; Yang H
BMC Med Imaging; 2023 Sep; 23(1):122. PubMed ID: 37697248
[TBL] [Abstract][Full Text] [Related]
9. A new classification and regression tree algorithm: Improved diagnostic sensitivity for HCC ≤ 3.0 cm using gadoxetate disodium-enhanced MRI.
Pan J; Ye S; Song M; Yang T; Yang L; Zhu Y; Zhao Y; Chen F
Eur J Radiol; 2023 May; 162():110770. PubMed ID: 36933495
[TBL] [Abstract][Full Text] [Related]
10. Based on Gadolinium Ethoxybenzyl DTPA-Enhanced MRI: Diagnostic Performance of the Category-Modified LR-5 Criteria in Patients At Risk for Hepatocellular Carcinoma.
Li S; Deng K; Qiu J; Wang P; Yin D; Xie Y; Yu Y
Technol Cancer Res Treat; 2024; 23():15330338241256859. PubMed ID: 38780516
[No Abstract] [Full Text] [Related]
11. Comparison of CT and gadoxetic acid-enhanced MRI with liver imaging reporting and data system to assess liver tumors before resection.
Chen MF; Ho MC; Kao JH; Hwang RM; Deng SB; Yen KC; Liang PC; Wu CH
J Formos Med Assoc; 2024 Mar; 123(3):318-324. PubMed ID: 38044205
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline.
Zhang Y; Li Q; Li L; Hong Y; Qiang B; Yu Y; Guo R; Deng H; Han X; Zou X; Guo Z; Zhou J
Ultrasound Med Biol; 2024 Feb; 50(2):243-250. PubMed ID: 37985306
[TBL] [Abstract][Full Text] [Related]
13. Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 cm: Biological Characteristics and Patient Outcomes.
Cai WJ; Ying M; Zheng RQ; Liao J; Luo B; Tang L; Cheng W; Yang H; Wei A; Yang Y; Wang H; Luo YC; Liu C; Zhong H; Yang Q; Yu J; Liang P
Liver Cancer; 2023 Sep; 12(4):356-371. PubMed ID: 37817756
[TBL] [Abstract][Full Text] [Related]
14. Surveillance for malignant progression of LI-RADS version 2017 category 3/4 nodules using contrast-enhanced ultrasound.
Huang H; Li CQ; He DN; Ruan SM; Li MD; Cheng MQ; Lu MD; Kuang M; Wang W; Wang Y; Chen LD
Eur Radiol; 2023 Dec; 33(12):9336-9346. PubMed ID: 37405501
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Time Difference Method in Identifying Hepatocellular Carcinoma in Current CEUS LR-M Category Nodules.
Shao LJ; Wang YJ; Yin SS; Jiang BB; Liu YH; Wang JC; Yang W; Wu W; Yan K
Ultrasound Med Biol; 2024 Apr; 50(4):502-508. PubMed ID: 38246805
[TBL] [Abstract][Full Text] [Related]
16. Deep learning nomogram based on Gd-EOB-DTPA MRI for predicting early recurrence in hepatocellular carcinoma after hepatectomy.
Yan M; Zhang X; Zhang B; Geng Z; Xie C; Yang W; Zhang S; Qi Z; Lin T; Ke Q; Li X; Wang S; Quan X
Eur Radiol; 2023 Jul; 33(7):4949-4961. PubMed ID: 36786905
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of modified contrast-enhanced ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) using Sonazoid in diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
Liu Q; Liu T; Liu X; Zhang F; Yang J; Cheng Y; Yang Q
Quant Imaging Med Surg; 2024 Apr; 14(4):2927-2937. PubMed ID: 38617149
[TBL] [Abstract][Full Text] [Related]
18. A model incorporating clinicopathologic and liver imaging reporting and data system-based magnetic resonance imaging features to identify hepatocellular carcinoma in LR-M observations.
Hu XX; Bai D; Wang ZL; Zhang Y; Zhao J; Li ML; Yang J; Zhang L
Diagn Interv Radiol; 2023 Nov; 29(6):741-752. PubMed ID: 37665140
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound in the detection of intrahepatic lesion.
Li J; Ye X; Wang J; Yuan G; He S
Medicine (Baltimore); 2022 Sep; 101(36):e30482. PubMed ID: 36086711
[TBL] [Abstract][Full Text] [Related]
20. Change in Liver Imaging Reporting and Data System Characterization of Focal Liver Lesions Using Gadoxetate Disodium Magnetic Resonance Imaging Compared With Contrast-Enhanced Computed Tomography.
Hope TA; Aslam R; Weinstein S; Yeh BM; Corvera CU; Monto A; Yee J
J Comput Assist Tomogr; 2017; 41(3):376-381. PubMed ID: 27801693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]